...
首页> 外文期刊>Chemical engineering journal >Preparation of tPA-loaded microbubbles as potential theranostic agents: A novel one-step method via coaxial electrohydrodynamic atomization technique
【24h】

Preparation of tPA-loaded microbubbles as potential theranostic agents: A novel one-step method via coaxial electrohydrodynamic atomization technique

机译:负载tPA的微泡作为潜在的治疗剂的制备:通过同轴电动流体雾化技术的一种新颖的一步法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the present work, we demonstrated for the first time a simple method for the fabrication of drug loaded Microbubbles (MBs) by a single step via coaxial electrohydrodynamic atomization (CEHDA). As a proof of concept, a therapeutic agent (tissue plasminogen activator, tPA) and two types of shell materials (phospholipid and bovine serum albumin, BSA) were selected to produce tPA-entrapped MBs. Investigation using fluorescein isothiocyanate (FITC) labelled tPA revealed that the tPA-loaded MBs were successfully fabricated in a one-step procedure and the tPA was located in the shell layer for both the BSA and lipid MBs. By optimization of the operating conditions in terms of voltage, core/shell flow rate ratio as well as tPA volume ratio, minimum bubble sizes for tPA-BSA and tPA-lipid MBs were obtained. The fabricated tPA-BSA MBs was 41 mu m in mean diameter while similar to 41% of the tPA-lipid MBs ranged from 3 to 6 mu m and similar to 36% of them ranged from 6 to 9 mu m under optimal operating conditions. Sensitivity analysis on the effects of key process parameters was also performed to guide design and manipulation of bubble sizes. The investigation of gas phase showed that the usage of sulphur hexafluoride (SF6) as the core can enhance the stability of tPA-lipid bubbles. The presented one-step method displayed great flexibility for producing tPA-loaded MBs and thus can potentially serve as a new tool to generate/engineer tPA-bubbles for applications in ischemic stroke therapy. (C) 2016 Elsevier B.V. All rights reserved.
机译:在本工作中,我们首次展示了一种简单的方法,可通过同轴电流体动力学雾化(CEHDA)一步完成载药微泡(MBs)的制备。作为概念证明,选择了一种治疗剂(组织纤维蛋白溶酶原激活剂,tPA)和两种类型的壳材料(磷脂和牛血清白蛋白,BSA)来生产包裹tPA的MB。使用异硫氰酸荧光素(FITC)标记的tPA进行的研究表明,以一步法成功制备了装载tPA的MB,并且tPA位于BSA和脂质MB的壳层中。通过在电压,核/壳流速比以及tPA体积比方面优化工作条件,可获得tPA-BSA和tPA-脂质MB的最小气泡尺寸。在最佳操作条件下,制造的tPA-BSA MB的平均直径为41μm,而相似的tPA-脂质MBs的41%介于3至6μm之间,接近36%的tPA-BSA MB为6至9μm之间。还对关键工艺参数的影响进行了敏感性分析,以指导气泡尺寸的设计和操纵。气相研究表明,以六氟化硫(SF6)为核芯可以增强tPA-脂质气泡的稳定性。提出的一步法显示了生产tPA负载的MB的巨大灵活性,因此可以潜在地用作生成/工程化tPA气泡的新工具,用于缺血性中风治疗。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号